Podcast: OxSonics Hopes To Use Ultrasound To Enhance Drug Efficacy – Without Reformulation

In this one-off podcast, reporter Barnaby Pickering speaks Jérôme Marzinski and Dr Christian Coviello, the CEO and CTO, respectively, of OxSonics, a UK-based start-up which is working on an ultrasound-based technology that has been designed to enhance the potency of oncological drugs. Also joining the discussion was Matthew Frohn, Partner at Longwall Ventures, one of Oxsonic’s investors.